Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125622922 | 12562292 | 2 | F | 20160609 | 20160806 | 20160715 | 20160812 | EXP | FR-PURDUE PHARMA-GBR-2016-0039088 | PURDUE | 82.12 | YR | M | Y | 0.00000 | 20160810 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125622922 | 12562292 | 1 | SS | OxyNormORO comprime orodispersible 5 mg | OXYCODONE HYDROCHLORIDE | 1 | Oral | UNK UNK, PRN | U | 0 | ORODISPERSIBLE TABLET | ||||||||
| 125622922 | 12562292 | 2 | PS | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Oral | 1 DF, DAILY | U | U | 22272 | 1 | DF | PROLONGED-RELEASE TABLET | |||||
| 125622922 | 12562292 | 3 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 1 MG, DAILY | U | U | 0 | 1 | MG | ||||||
| 125622922 | 12562292 | 4 | SS | XTANDI | ENZALUTAMIDE | 1 | Oral | 160 MG, DAILY | U | U | 0 | 160 | MG | ||||||
| 125622922 | 12562292 | 5 | SS | CASODEX | BICALUTAMIDE | 1 | Oral | 1 DF, DAILY | U | U | 0 | 1 | DF | TABLET | |||||
| 125622922 | 12562292 | 6 | SS | LACTULOSE. | LACTULOSE | 1 | Oral | 2 DF, DAILY | U | U | 0 | 2 | DF | ||||||
| 125622922 | 12562292 | 7 | SS | BISOPROLOL | BISOPROLOL | 1 | Oral | 1.25 MG, DAILY | U | U | 0 | 1.25 | MG | ||||||
| 125622922 | 12562292 | 8 | SS | NICORANDIL | NICORANDIL | 1 | Oral | 1 DF, DAILY | U | U | 0 | 1 | DF | ||||||
| 125622922 | 12562292 | 9 | SS | KARDEGIC | ASPIRIN LYSINE | 1 | Oral | 1 DF, DAILY | U | U | 0 | 1 | DF | ||||||
| 125622922 | 12562292 | 10 | SS | DIFFU K | POTASSIUM CHLORIDE | 1 | Oral | 1 DF, DAILY | 10 | DF | U | 0 | 1 | DF | |||||
| 125622922 | 12562292 | 11 | SS | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | Oral | 1 DF, DAILY | U | U | 0 | 1 | DF | ||||||
| 125622922 | 12562292 | 12 | SS | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | 1 MG, DAILY | U | 0 | 1 | MG | |||||||
| 125622922 | 12562292 | 13 | SS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 1 DF, DAILY | U | 0 | 1 | DF | FILM-COATED TABLET | ||||||
| 125622922 | 12562292 | 14 | SS | DOLIPRANE | ACETAMINOPHEN | 1 | Oral | UNK, PRN | U | U | 0 | ||||||||
| 125622922 | 12562292 | 15 | SS | NORMACOL | KARAYA GUM | 1 | Rectal | UNK | U | U | 0 | ||||||||
| 125622922 | 12562292 | 16 | C | NOVORAPID | INSULIN ASPART | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | |||||||||
| 125622922 | 12562292 | 17 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | |||||||||
| 125622922 | 12562292 | 18 | C | LYSANXIA | PRAZEPAM | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125622922 | 12562292 | 1 | Pain |
| 125622922 | 12562292 | 2 | Pain |
| 125622922 | 12562292 | 3 | Product used for unknown indication |
| 125622922 | 12562292 | 4 | Prostate cancer |
| 125622922 | 12562292 | 5 | Prostate cancer |
| 125622922 | 12562292 | 6 | Constipation |
| 125622922 | 12562292 | 7 | Hypertension |
| 125622922 | 12562292 | 8 | Angina unstable |
| 125622922 | 12562292 | 9 | Cardiovascular event prophylaxis |
| 125622922 | 12562292 | 10 | Hypokalaemia |
| 125622922 | 12562292 | 11 | Gastrooesophageal reflux disease |
| 125622922 | 12562292 | 12 | Hypercholesterolaemia |
| 125622922 | 12562292 | 13 | Diabetes mellitus |
| 125622922 | 12562292 | 14 | Pain |
| 125622922 | 12562292 | 15 | Constipation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125622922 | 12562292 | HO |
| 125622922 | 12562292 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125622922 | 12562292 | Hepatic encephalopathy | |
| 125622922 | 12562292 | Hepatic function abnormal | |
| 125622922 | 12562292 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125622922 | 12562292 | 1 | 20160526 | 0 | ||
| 125622922 | 12562292 | 2 | 20160526 | 0 | ||
| 125622922 | 12562292 | 3 | 20160606 | 0 | ||
| 125622922 | 12562292 | 4 | 20160524 | 0 | ||
| 125622922 | 12562292 | 5 | 20160210 | 0 | ||
| 125622922 | 12562292 | 6 | 20160528 | 0 | ||
| 125622922 | 12562292 | 7 | 20151127 | 0 | ||
| 125622922 | 12562292 | 10 | 20160528 | 20160606 | 0 | |
| 125622922 | 12562292 | 11 | 20160606 | 0 | ||
| 125622922 | 12562292 | 12 | 20160606 | 0 | ||
| 125622922 | 12562292 | 13 | 20160606 | 0 | ||
| 125622922 | 12562292 | 15 | 20160507 | 0 | ||
| 125622922 | 12562292 | 16 | 20160509 | 0 | ||
| 125622922 | 12562292 | 17 | 20160509 | 0 | ||
| 125622922 | 12562292 | 18 | 20160510 | 0 |